Interleukin-13 protects endothelial cells from apoptosis and activation: Association with the protective genes A20 and A1

Transplantation

Volumn 70, Issue 6, 2000, Pages 928-934

  Evans, Paul C ^a   Kilshaw, Peter J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT INTERLEUKIN 13; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; PRIORITY JOURNAL;

EID: 0034721486     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200009270-00010     Document Type: Article

References (41)

1. Chronic remodeling pathology in grafts
2. Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy
3. Alloimmune-mediated apoptosis - Comparison in mouse models of acute and chronic cardiac rejection
4. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants - Influence of Fas-mediated apoptosis
5. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease
6. Accommodation of vascularised xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment
7. Antibody-induced transplant arteriosclerosis is prevented by expression of anti-oxidant and anti-apoptotic genes
8. Interleukin-4 and interleukin-13: Their similarities and discrepancies
9. Interleukin-13, in combination with anti-interleukin-12, increases graft prolongation after portal venous immunization with cultured allogeneic bone marrow-derived dendritic cells
10. Overexpression of A1, an NF-kappa B-inducible anti-apoptotic Bcl gene, inhibits endothelial cell activation
11. Bcl-2 and Bcl-X-L serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappa B
12. Lipopolysaccharide induces the antiapoptotic molecules A1 and A20 in microvascular endothelial cells
13. Vascular endothelial cell growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
14. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides
15. Culture of human endothelial cells from umbilical vein: Identification by morphological and immunological criteria
16. Single-step method of RNA isolation by acid guanidinium thiocyonate-phenol-chloroform extraction
17. Measurement of mRNA for E-selectin, VCAM-1 and ICAM-1 by reverse transcription and the polymerase chain reaction
18. Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy
19. Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction
20. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection from apoptosis
21. A20 inhibits NF-kB activation in endothelial cells without sensitizing to tumour necrosis factor-mediated apoptosis
22. A20 zinc finger protein inhibits TNF and IL-1 signaling
23. The tumour necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation
24. The cytokine-inducible zinc finger protein A20 inhibits IL1-induced NF-kB activation at the level of TRAF6
25. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN
26. Endothelial cell death induced by tumour necrosis factor-α is inhibited by the bcl-2 family member, A1
27. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13
28. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein A20 is mediated by κB elements
29. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells
30. Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NK-κB-independent mechanism
31. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ chain
32. IL-4 and IL-13 activate the JAK2 tyrosine kinase and STAT6 in cultured human vascular endothelial cells through a common pathway that does not involve the γc chain
33. Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4Rα and STAT6 phosphorylation
34. Interleukin-4 suppression of tumour necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB
35. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
36. Retrograde inflammatory signalling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha
37. Preparations of lymphotoxin induce resistance to their own cytotoxic effect
38. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NK-κB activation prevents cell death
39. Thrombin induces endothelial type II activation in vitro: II-1 and TNF-α-independent IL-8 secretion and E-selectin expression
40. Regulation of endothelial and mesothelial cell function by interleukin-13: Selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production
41. Sustained elevated levels of VCAm-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability